Mexico Targets Medicine Access, Self-Sufficiency
By Sofía Garduño | Journalist & Industry Analyst -
Thu, 05/29/2025 - 10:00
This week, Mexico moved to boost medicine access with the upcoming Pharmacies for Well-Being program and a push for pharmaceutical self-sufficiency through nearshoring. In other news. Medtronic will spin off its diabetes unit to sharpen focus, while the global neurology market is set to reach US$94.8 billion by 2029 amid rising demand.
This is The Week in Health!
Sheinbaum Launches Pharmacies for Well-Being Network
President Claudia Sheinbaum announced that the installation of the Pharmacies for Well-Being program will begin in August 2025. This program is part of the administration’s broader strategy to strengthen the public healthcare system and improve access to essential medicines in underserved areas.
Mexico Eyes Pharmaceutical Self-Sufficiency to Boost Access
Mexico aims to shift from relying on pharmaceutical imports to becoming a hub for local production and export, says Deputy Minister of Health Eduardo Clark. The country’s strategic location near North American markets, combined with a sizable public health sector patient base, positions it well for pharmaceutical nearshoring, he adds.
Menstrual Hygiene Day: Mexico Still Falling Behind
Menstrual Hygiene Day (MH Day) is celebrated on May 28, representing a global call to end period poverty and menstrual stigma by 2030. Yet in Mexico, despite urgent needs, only 15 of the 32 states have enacted laws addressing menstrual health education and access.
Medtronic to Spin Off Diabetes Unit
Medtronic announced it will separate its diabetes business into a standalone company, a move aimed at sharpening the company’s focus on high-margin, innovation-driven growth segments in the MedTech sector.
Aging Population Drives Neurology Market to US$94.8 Billion
The global neurology market is expected to grow from US$67.3 billion in 2024 to US$94.8 billion by 2029, according to a new report from BCC Research. The forecast reflects a compound annual growth rate of 7.1% driven by demographic shifts, increased disease prevalence, and expanding healthcare access.

